Lifeward appoints Bob Marshall as board chairman

Lifeward Ltd. (NASDAQ: LFWD) announced that its board of directors has appointed Bob Marshall as chairman of the board, effective January 1, 2026. Marshall replaces Joseph Turk, who is transitioning off the board in connection with his new position at Fresenius Medical Care.

Marshall currently serves as chief financial officer and treasurer of Lantheus Holdings, a publicly traded radiopharmaceutical company, positions he has held since 2018. He previously spent 16 years at Zimmer Biomet Holdings in various roles including vice president of investor relations and corporate treasurer, and most recently vice president of Americas finance for U.S., Canadian, and Latin American commercial markets.

Marshall has served as a board member and chair of Lifeward's audit committee since joining in 2024. Prior to his tenure at Zimmer Biomet, he held positions at Brown & Williamson Tobacco, a subsidiary of British American Tobacco.

"On behalf of the Board and entire Lifeward team, I congratulate Joe on his appointment as Chief Executive Officer of Care Enablement at Fresenius Medical Care," said Lifeward CEO Mark Grant. "We are grateful for Joe's leadership and dedicated service to Lifeward, including his stewardship as Chairman."

Grant added that Marshall's "financial leadership, healthcare public company expertise, and strategic perspective will be instrumental as we continue to execute on our strategic growth plans and deliver improved care and outcomes for patients."

Lifeward designs and commercializes medical technology solutions for physical rehabilitation and recovery, including the ReWalk Exoskeleton, AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System. The company was founded in 2001 and operates in the United States, Israel, and Germany.

You May Also Be Interested In

• Merck and Moderna melanoma drug combo cuts recurrence risk by 42%
• Rosenblatt Reiterates Buy Rating on Meta Platforms Inc. (META); 'Capital Raise Talk is Minimal Relative to Meta's Size'
• Vylor board approves $3 billion share repurchase program